期刊文献+

先天性巨结肠症肠壁微环境改变的免疫组织化学研究 被引量:6

Immunohistochemical study of microenvironmental changes in intestinal wall of Hirschsprung's disease
原文传递
导出
摘要 目的 观察先天性巨结肠症 (HD)患者肠壁中细胞外基质成分———Ⅳ型胶原 (ColⅣ )及其降解酶 基质金属蛋白酶 2 (MMP 2 )的分布 ,探讨肠壁微环境改变与HD发病机制间的关系。方法 采用SABC免疫组化法 ,分别观察 37例HD患者的无神经节细胞、有神经节细胞及近端正常肠组织中ColⅣ和MMP 2的分布。结果 无神经节细胞肠壁ColⅣ的含量高于有神经节细胞段和正常段肠组织 ,差异有显著性意义 ,χ2 分别为 13.2 1和 14 .96 ,P值均为 0 .0 0 0 ;无神经节细胞肠壁中MMP 2含量也显著高于其他节段 ,χ2 分别为 6 .2 9和 5 .0 9,P值为 0 .0 12和 0 .0 2 4 ;有神经节细胞段与正常段ColⅣ和MMP 2的分布基本一致 ,没有明显差别。结论 肠壁微环境的异常在HD发病中充当了重要角色 ,其中细胞外基质成分ColⅣ及其降解酶MMP 2在无神经节细胞肠段中的异常增多提示异常的微环境可能影响了神经嵴母细胞的肠内迁移、定位及其后的分化和成熟 ,从而导致HD。 Objective To observe the distribution of extracellular matrix component, collagen(Col Ⅳ) and its proteinase, matrix metalloproteinase 2 (MMP 2) in Hirschsprung's disease (HD), and explore the relationship between microenvironmental change of intestinal wall and pathogenesis of HD. Methods SABC complex immunohistochemical method was utilized to visualize the distribution of collagen and MMP 2 in aganglionic, ganglionic and proximal segments from 37 HD patients. Results Col immunoreactivity was markedly increased in the aganglionic segments as compared with the ganglionic and normal segments ( χ 2 = 13.211 and 14.957 respectively, P = 0.000 ). Staining intensity of MMP 2 in aganglionic segments was also stronger than those in the other two segments ( χ 2 = 6.288 and 5.089 , P = 0.012 and 0.024 respectively). But the distribution of Col and MMP 2 in ganglionic and normal bowel segments of HD patients were approximately the same. Conclusions Anomalies of microenvironment in bowel wall play an important role in the development of HD. The remarkable increase of collagen (a component of extracellular matrix) and its proteinase, MMP 2 in aganglionic bowel segments indicate that the microenvironmental anomalies may cause HD by affecting migration, colonization, differentiation and maturation of the neural crest derived neuroblasts.
出处 《中华小儿外科杂志》 CSCD 北大核心 2003年第2期113-115,共3页 Chinese Journal of Pediatric Surgery
关键词 先天性巨结肠 免疫组织化学 细胞外基质 胶原 金属蛋白酶类 神经节细胞学 Hirschsprung's disease,congenital Immunohistochemistry, methods Extracellular matrix Collagen Metalloproteinases Ganglia, cytology
  • 相关文献

参考文献2

二级参考文献10

  • 1刘贵麟,王德文,李力军,张喜恩,彭少林.人胚胎消化道神经节细胞发育的研究[J].中华小儿外科杂志,1996,17(1):31-33. 被引量:2
  • 2Rothman T P,Devel,1996年,178卷,1期,498页
  • 3刘贵麟,中华小儿外科杂志,1996年,7卷,6期,324326页
  • 4Meijers J H C,J Pediatr Surg,1989年,24卷,2期,557页
  • 5Thomas Krieg,E. Carwile LeRoy. Diseases of the extracellular matrix[J] 1998,Journal of Molecular Medicine(3-4):224~225
  • 6Leena Bruckner-Tuderman,P. Bruckner. Genetic diseases of the extracellular matrix: more than just connective tissue disorders[J] 1998,Journal of Molecular Medicine(3-4):226~237
  • 7M. Aumailley,B. Gayraud. Structure and biological activity of the extracellular matrix[J] 1998,Journal of Molecular Medicine(3-4):253~265
  • 8K. Gohji,M. Nomi,I. Hara,S. Arakawa,S. Kamidono. Influence of cytokines and growth factors on matrix metalloproteinase-2 production and invasion of human renal cancer[J] 1998,Urological Research(1):33~37
  • 9B. Huppertz,Sonja Kertschanska,Ayse Yasemin Demir,Hans-Georg Frank,Peter Kaufmann. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta[J] 1997,Cell & Tissue Research(1):133~148
  • 10L.J. Denis,J. Verweij. Matrix metalloproteinase inhibitors: Present achievements and future prospects[J] 1997,Investigational New Drugs(3):175~185

共引文献45

同被引文献52

  • 1周晨慧,彭惠民.单核苷酸多态性检测方法的评价[J].现代医药卫生,2005,21(2):156-157. 被引量:3
  • 2Wu TT, Tsai TW, Chu CF, et al. Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease and Taiwan. J Hum Genet, 2005, 50: 168-174.
  • 3Garavelli L, Donadio A, Zanacca C, et al. Hirschsprung disease, mental retardation, characteristic facial features, and mutation in the gene ZFHX1B ( SIP1 ) : confirmation of the Mowat-Wilson sydrome. Am J Med Genet, 2003,116 : 385-388.
  • 4van de Putte T, Maruhashi M, Francis A, et al. Mice lacking ZFHX1B, the gene that codes for smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of hirschsprung disease-mental retardation syndrome. Am J Hum Genet, 2003,72:465-470.
  • 5Amiel J, Espinosa-Parrilla Y, Steffann J, et al. Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet, 2001,69:1370-1377.
  • 6Nagaya M, Kato J, Niimi N, et al. Clinical features of a form of Hirschsprung's disease caused by a novel genetic abnormality. J Pediatr Surg, 2002, 37:1117-1122.
  • 7Yamada K, Yamada Y, Nomura N,et al. Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical features. AM J Hum Genet, 2001, 69:1178-1185.
  • 8Martucciello G, Ceccherini I, Lerone M, et al. Pathogenesis of Hirschsprung' s disease. J Pediatr Surg, 2000, 35 : 1017-1025.
  • 9Fitze G, Cramer J, Ziegler A, et al. Association between c135G/A genotype and RET proto-oncogene germLine mutations and phenotype of Hirschsprung' s disease. Lancet, 2002,359 : 1200-1205.
  • 10Mowat DR, Croaker GD, Cass DT, et al. Hirschsprung disease, microcephaly, mental retardation, and charateristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet, 1998, 35:617-623.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部